Clinical trials for Hepatitis Delta Virus in the WHO African region: A neglected virus among neglected viruses
Delphin M. et al, (2025), Journal of Infection, 91, 106514 - 106514
Identification of undetected SARS-CoV-2 infections by clustering of Nucleocapsid antibody trajectories.
Zwerwer LR. et al, (2025), Nat Commun, 16
Community engagement and chronic viral hepatitis public health interventions: a systematic review, meta-analysis, and complementary crowdsourcing open call
Li Y. et al, (2025), eClinicalMedicine, 83
Hepatitis B virus resistance to nucleos(t)ide analogue therapy: WHO consultation on questions, challenges, and a roadmap for the field.
Lumley SF. et al, (2025), Lancet Microbe
Impact of metformin on HBV replication: No evidence of suppression in vitro.
Hawkins C. et al, (2025), J Clin Virol, 177
Pathogens don't respect politicians: US federal disruption poses a new threat to global public health.
Wang S. et al, (2025), Lancet Gastroenterol Hepatol, 10, 291 - 292
Infecting minds: socio-contextual drivers of vaccine perceptions and attitudes among young and older adults living in urban and rural areas in KwaZulu-Natal, South Africa.
Orievulu KS. et al, (2025), BMC Public Health, 25
Hepatitis B Core-Related Antigen Point-of-Care Tests as a Risk Stratification Tool for Treatment Eligibility: Experience From Kenya.
Downs LO. et al, (2025), Open Forum Infect Dis, 12
A putative hepatitis B virus sequence motif associated with hepatocellular carcinoma in South African adults.
Maponga TG. et al, (2025), Ann Hepatol, 30
Whole genome sequencing of hepatitis B virus using tiled amplicon (HEPTILE) and probe based enrichment on Illumina and Nanopore platforms.
Lumley SF. et al, (2025), Sci Rep, 15
Elimination of hepatitis B requires recognition of catastrophic costs for patients and their families.
Jemutai J. et al, (2025), Lancet Gastroenterol Hepatol, 10, 100 - 103
Reply to: "Understanding virologic heterogeneity in chronic hepatitis B treatment".
Matthews PC. et al, (2025), JHEP Rep, 7
Knowledge, attitudes and practices to hepatitis B among South African primary healthcare staff.
Mashilo A. et al, (2025), Afr J Prim Health Care Fam Med, 17, e1 - e8
Distinct virologic trajectories in chronic hepatitis B identify heterogeneity in response to nucleos(t)ide analogue therapy.
Wang T. et al, (2025), JHEP Rep, 7
Using Laboratory Test Results for Surveillance During a New Outbreak of Acute Hepatitis in 3-Week- to 5-Year-Old Children in the United Kingdom, the Netherlands, Ireland, and Curaçao: Observational Cohort Study.
Swets MC. et al, (2024), JMIR Public Health Surveill, 10